Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Current Clinical Pharmacology|January 31, 2012
Targeting Spinal Long-Term Potentiation as a Basis for Analgesia Recent DevelopmentsOliver Adolph, Karl Josef FöhrAnesthesiology|July 15, 2011
Intranasal application of xenon reduces opioid requirement and postoperative pain in patients undergoing major abdominal surgery: a randomized controlled trialThorsten Frederik Holsträter, Michael Georgieff, Karl Josef Föhr, et al.International Journal of Molecular Sciences|November 11, 2022
Block of Voltage-Gated Sodium Channels by Aripiprazole in a State-Dependent MannerKarl Josef Föhr, Michael Rapp, Michael Fauler, et al.FEBS Open Bio|July 31, 2025
Blocking the voltage-gated sodium channel hNav1.5 as a novel pH-dependent mechanism of action for tamoxifenKarl Josef Föhr, Michael Fauler, Thomas Zimmer, et al.Frontiers in Pharmacology|March 18, 2021
Block of Voltage-Gated Sodium Channels by Atomoxetine in a State- and Use-dependent MannerKarl Josef Föhr, Ariadni Nastos, Michael Fauler, et al.Current Clinical Pharmacology|August 25, 2016
In Vivo Measurement in Pigs of Wash-In Kinetics of Xenon at its Site of ActionGebhard Froeba, Oliver AdolphFrontiers in Pharmacology|November 8, 2021
Block of Voltage-Gated Sodium Channels as a Potential Novel Anti-cancer Mechanism of TIC10Eva Fuchs, David Alexander Christian Messerer, Georg Karpel-Massler, et al.Current Clinical Pharmacology|January 28, 2012
Targeting spinal long-term potentiation as a basis for anlagesia: recent developmentsOliver Adolph, Karl Josef FohrActa Neurobiologiae Experimentalis|July 14, 2009
In vitro-evaluation of lipid emulsions as vehicles for the administration of xenon: interaction with NMDA receptorsHenry U Weigt, Michael Georgieff, Karl J Fohr, et al.Neuropharmacology|August 19, 2015
Open channel block of NMDA receptors by diphenhydramineKarl J Föhr, Kathrin Zeller, Michael Georgieff, et al.Pageof 3